信盛礦業(02133.HK)料3月底前開展2022年報審計工作
信盛礦業(02133.HK)公布,鑑於緬甸局勢最新狀況和疫情發展,為保障集團員工及審計師之生命安全,審計團隊暫時難以親身到集團的緬甸礦場收集所有必要的審計證據。假設緬甸局勢於本年內有改善、疫情得到有效控制及沒有發生不可預見的其他事宜的前提下,預計將於3月31日或之前開展截止2022年報審計工作、刊發2020至2022年年報。
目前,公司正在推進各個礦山項目的資產盤活和生產經營恢復,並積極尋求合作夥伴共同發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.